Latest Articles

Publication Date
Fertility Clinics Must End Unproven Treatments, Says NICE - Medscape

Fertility Clinics Must End Unproven Treatments, Says NICE Medscape

Published: Sept. 10, 2025, 6 p.m.
What makes NICE stock price move sharply - Free Earnings Play Trade Plan With Alerts - Newser

What makes NICE stock price move sharply - Free Earnings Play Trade Plan With Alerts Newser

Published: Aug. 8, 2025, 5:49 p.m.
MSD receives NICE recommendation for Keytruda in advanced endometrial cancer - PMLiVE

MSD receives NICE recommendation for Keytruda in advanced endometrial cancer PMLiVE

Published: Aug. 8, 2025, 11:07 a.m.
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes

NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes

Published: Aug. 7, 2025, 9:15 a.m.
NICE approves first immunotherapy combination for endometrial cancer - Wired Gov

NICE approves first immunotherapy combination for endometrial cancer Wired Gov

Published: Aug. 6, 2025, 1:13 p.m.
First immunotherapy combination for endometrial cancer approved by NICE - Oncology Central

First immunotherapy combination for endometrial cancer approved by NICE Oncology Central

Published: Aug. 6, 2025, 11:18 a.m.
NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer - NAVLIN DAILY

NICE Recommends Keytruda Combination for First-Line Treatment of Advanced Endometrial Cancer NAVLIN DAILY

Published: Aug. 6, 2025, 9:30 a.m.
NICE recommends Keytruda for endometrial cancer - The Pharma Letter

NICE recommends Keytruda for endometrial cancer The Pharma Letter

Published: Aug. 6, 2025, 6:49 a.m.
NICE approves first immunotherapy combination for endometrial cancer - NICE website

NICE approves first immunotherapy combination for endometrial cancer NICE website

Published: Aug. 5, 2025, 11 p.m.
NICE approves new at-home treatment for endometriosis - Pharmacy Business

NICE approves new at-home treatment for endometriosis Pharmacy Business

Published: May 2, 2025, 5:23 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!